<DOC>
	<DOCNO>NCT01111773</DOCNO>
	<brief_summary>The purpose study explore potential usefulness heat lidocaine 70 mg tetracaine 70 mg topical patch treatment pain associate patellar tendinopathy .</brief_summary>
	<brief_title>Study Evaluating Heated Lidocaine Tetracaine Topical Patch Treatment Patients With Patellar Tendinopathy</brief_title>
	<detailed_description>The purpose pilot study explore potential usefulness heat lidocaine 70 mg tetracaine 70 mg topical patch treatment pain associate patellar tendinopathy . A number efficacy variable employ evaluate utility assess painful response population . The study 2-week , open-label study conduct single study site patient pain associated patellar tendinopathy single knee . During out-patient study , patient apply one study patch affect tendon twice daily approximately 14 day . Patches apply morning evening ( application separate approximately 8-10 hour ) remove 2-4 hour .</detailed_description>
	<mesh_term>Tendinopathy</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<criteria>least 18 year age pain associate patellar tendinopathy single knee ( minimum 2week duration ) tenderness proximal insertion patellar tendon affect knee history surgery target knee use topically applied pain medication target treatment area within 3 day precede Screening/Baseline Visit inject steroid target knee within 3 month Screening/Baseline Visit use injected pain medication within 14 day precede Screening/Baseline Visit receive class 1 antiarrhythmic drug ( ie , tocainide , mexiletine , etc . ) Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Patellar tendonitis</keyword>
</DOC>